Understand your treatment before you begin.
Treatment requires an individual clinical evaluation. Information on this website is educational and does not replace instructions from your treating provider or pharmacist.
Compounded medicines are not FDA-approved
FDA does not review compounded medicines for safety, effectiveness or quality before marketing. Problems with contamination or ingredient strength can cause serious harm. A compounded product is not an FDA-approved generic or an assurance of equivalence to a branded medicine. Read FDA’s explanation of compounding risks.
GLP-1 products and formulations
FDA advises using compounded drugs only when a patient’s medical needs cannot be met by an FDA-approved drug. Ask your provider whether an approved treatment can meet your needs. Do not assume that oral, liposomal, injectable or combination products have interchangeable effects or evidence. Read FDA’s concerns about unapproved GLP-1 drugs.
Dosing errors and adverse effects
FDA has received reports of dosing errors with compounded injectable semaglutide, including cases requiring hospitalization. Reported overdose effects include nausea, vomiting, abdominal pain, dehydration, pancreatitis and gallstones. These examples are not a complete list of potential side effects. Read FDA’s dosing-error alert.
Ask your provider and pharmacist to explain your exact dose, concentration, measurement device, storage and disposal instructions. Do not change your dose or combine products without their direction. Contact the clinical team about unexpected symptoms or unclear instructions.
Who should use extra caution?
Only your clinician can determine whether a specific treatment is appropriate. Tell them about allergies, all medications and supplements, medical conditions, pregnancy or breastfeeding, and future pregnancy or fertility plans. Ask for the product-specific risks, contraindications and alternatives before consenting.
What does this website not promise?
Product images are illustrative. Program names such as “longevity,” “microdosing” or “performance” do not establish a medical indication, FDA approval or a guaranteed outcome. Individual results vary. A clinical review may result in a recommendation against treatment.
Where should I ask questions?
Use your patient hub for questions about your plan, prescriptions and follow-up. In a medical emergency, call 911 or seek emergency care; do not wait for an online reply.
Information updated October 2, 2026. This educational information does not replace advice from your treating clinician.
Safety information by program
Read the additional treatment-specific information on each program page.
Get started